| Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, LifePak nutritional supplements, ageLOC Meta nutritional supplements, and Beauty Focus Collagen+ skin care supplements, as well as other weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands. The company promotes and sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah. |
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| LIPMAN ANDREW D | Director | Jan 23 | Sale | 42.27 | 1,000 | 42,270 | 65,393 | Jan 23 06:58 PM | | LIPMAN ANDREW D | Director | Dec 22 | Sale | 40.75 | 1,000 | 40,750 | 66,393 | Dec 22 05:50 PM | | CHANG JOSEPH Y | Chief Scientific Officer | Dec 18 | Option Exercise | 37.58 | 6,800 | 255,544 | 29,757 | Dec 20 05:15 PM | | NAPIERSKI RYAN S | President and CEO | Nov 25 | Option Exercise | 33.97 | 25,000 | 849,150 | 147,683 | Nov 28 04:48 PM | | NAPIERSKI RYAN S | President and CEO | Nov 25 | Sale | 38.45 | 25,000 | 961,250 | 122,683 | Nov 28 04:48 PM | | LIPMAN ANDREW D | Director | Nov 22 | Sale | 38.16 | 1,000 | 38,160 | 67,393 | Nov 22 05:40 PM | | LIPMAN ANDREW D | Director | Oct 21 | Sale | 35.92 | 1,000 | 35,920 | 68,393 | Oct 24 05:25 PM | | LIPMAN ANDREW D | Director | Sep 22 | Sale | 36.67 | 1,000 | 36,670 | 69,393 | Sep 22 06:17 PM | | Thomas James D | Chief Accounting Officer | Sep 07 | Sale | 39.19 | 1,602 | 62,782 | 12,722 | Sep 08 05:11 PM | | NAPIERSKI RYAN S | President and CEO | Aug 25 | Option Exercise | 34.24 | 25,000 | 856,100 | 147,683 | Aug 25 06:36 PM | | NAPIERSKI RYAN S | President and CEO | Aug 25 | Sale | 42.99 | 25,000 | 1,074,865 | 122,683 | Aug 25 06:36 PM | | LIPMAN ANDREW D | Director | Aug 22 | Sale | 45.01 | 1,000 | 45,010 | 70,393 | Aug 22 06:42 PM | | Hatchett Steven Keith | Chief Product Officer | Aug 18 | Sale | 46.78 | 5,500 | 257,290 | 49,431 | Aug 19 05:27 PM | | LIPMAN ANDREW D | Director | Jul 22 | Sale | 43.00 | 1,000 | 43,000 | 71,393 | Jul 22 05:30 PM | | LUND STEVEN | Exec. Chairman of the Board | Jun 23 | Sale | 45.18 | 17,129 | 773,839 | 20,800 | Jun 23 06:20 PM | | LIPMAN ANDREW D | Director | Jun 22 | Sale | 44.06 | 1,000 | 44,060 | 72,393 | Jun 22 06:36 PM | | LUND STEVEN | Exec. Chairman of the Board | Jun 22 | Sale | 45.01 | 800 | 36,008 | 22,975 | Jun 22 06:34 PM | | LUND STEVEN | Exec. Chairman of the Board | Jun 21 | Sale | 45.02 | 6,426 | 289,299 | 23,375 | Jun 22 06:34 PM | | LUND STEVEN | Exec. Chairman of the Board | Jun 17 | Sale | 45.01 | 900 | 40,513 | 26,600 | Jun 22 06:34 PM | | LUND STEVEN | Exec. Chairman of the Board | Jun 15 | Sale | 45.00 | 395 | 17,775 | 27,000 | Jun 15 06:34 PM | | LUND STEVEN | Exec. Chairman of the Board | Jun 13 | Sale | 43.83 | 51,300 | 2,248,555 | 27,200 | Jun 15 06:34 PM | | Lawrence Mark H | Chief Financial Officer | Jun 06 | Sale | 47.03 | 5,868 | 275,972 | 48,218 | Jun 08 06:08 PM | | CHANG JOSEPH Y | Chief Scientific Officer | Jun 01 | Option Exercise | 30.63 | 16,000 | 490,080 | 38,957 | Jun 02 06:15 PM | | CHANG JOSEPH Y | Chief Scientific Officer | Jun 01 | Sale | 46.57 | 16,000 | 745,058 | 22,957 | Jun 02 06:15 PM | | NAPIERSKI RYAN S | President and CEO | May 25 | Option Exercise | 34.24 | 25,000 | 856,100 | 147,683 | May 26 05:45 PM | | NAPIERSKI RYAN S | President and CEO | May 25 | Sale | 44.91 | 25,000 | 1,122,768 | 122,683 | May 26 05:45 PM | | LIPMAN ANDREW D | Director | May 23 | Sale | 44.95 | 1,000 | 44,950 | 70,214 | May 23 06:10 PM | | LUND STEVEN | Exec. Chairman of the Board | May 18 | Sale | 46.07 | 925 | 42,615 | 179,449 | May 18 05:28 PM | | LUND STEVEN | Exec. Chairman of the Board | May 16 | Sale | 45.25 | 21,200 | 959,300 | 180,374 | May 18 05:28 PM | | LIPMAN ANDREW D | Director | Apr 22 | Sale | 47.72 | 1,000 | 47,720 | 71,214 | Apr 22 05:24 PM | | LIPMAN ANDREW D | Director | Mar 22 | Sale | 47.40 | 1,000 | 47,400 | 72,214 | Mar 23 05:04 PM | | CHANG JOSEPH Y | Chief Scientific Officer | Mar 02 | Option Exercise | 30.63 | 3,423 | 104,846 | 26,380 | Mar 03 04:22 PM | | CHANG JOSEPH Y | Chief Scientific Officer | Mar 02 | Sale | 46.04 | 3,423 | 157,597 | 22,957 | Mar 03 04:22 PM | | NAPIERSKI RYAN S | President and CEO | Feb 25 | Option Exercise | 35.86 | 25,000 | 896,410 | 147,683 | Mar 01 05:51 PM | | NAPIERSKI RYAN S | President and CEO | Feb 25 | Sale | 47.40 | 25,000 | 1,185,046 | 122,683 | Mar 01 05:51 PM | | LIPMAN ANDREW D | Director | Feb 22 | Sale | 53.27 | 1,000 | 53,270 | 73,214 | Feb 23 04:33 PM |
|
